Methicillin-resistant Staphylococcus aureus: Misinterpretation and misrepresentation of active detection and isolation

Clinical Infectious Diseases

Volumn 47, Issue 9, 2008, Pages 1238-1239

  Farr, Barry M ^a   Jarvis, William R ^b,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Jarvis and Jason Associates   (United States)

^c Jason and Jarvis Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; BACTEREMIA; BACTERIUM DETECTION; BACTERIUM ISOLATION; DENMARK; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL READMISSION; INTENSIVE CARE UNIT; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SCREENING;

HUMANS; METHICILLIN RESISTANCE; PATIENT ISOLATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 53349174013     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/592119     Document Type: Letter

References (13)

1. McGinigle KL, Gourlay ML, Buchanan IB. The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review. Clin Infect Dis 2008; 46:1717-25.
2. Muto CA, Jernigan JA, Ostrowksy BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24:362-86.
3. Huang SS, Rifas-Shiman SL, Warren DK, et al. Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis 2007; 195:330-8.
4. Huang SS, Yokoe DS, Hinrichsen VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006; 43:971-8.
5. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999; 282:1745-51.
6. Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998; 27:543-50.
7. Farr BM. Doing the right thing (and figuring out what that is). Infect Control Hosp Epidemiol 2006; 27:999-1003.
8. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342:1887-92.
9. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000; 342:1878-86.
10. Huskins WC, O'Grady NP, Samore M, Wallace D, Goldmann DA, Pappas PG. Design and methodology of the Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR-ICU) trial. Infect Control Hosp Epidemiol 2007; 28:245-6.
11. Farr BM. What to think if the results of the National Institutes of Health randomized trial of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus control measures are negative (and other advice to young epidemiologists): a review and an au revoir. Infect Control Hosp Epidemiol 2006; 27:1096-106.
12. Tiemersma EW, Bronzwaer SL, Lyytikainen O, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10:1627-34.
13. Dailey L, Coombs GW, O'Brien FG, et al. Methicillin-resistant Staphylococcus aureus, Western Australia. Emerg Infect Dis 2005; 11:1584-90.